Literature DB >> 3599130

Preleukemia in Fanconi's anemia: hematopoietic cell multinuclearity, membrane duplication, and dysgranulogenesis.

J C Barton, R T Parmley, A J Carroll, S T Huang, L T Goodnough, H W Findley, A H Ragab.   

Abstract

A 25-year-old male had Fanconi's anemia characterized by small stature, the onset of pancytopenia in the first decade of life, a high spontaneous breakage rate of the chromosomes, and the development of acute myeloblastic leukemia. In the preleukemic phase, marrow erythroblasts were multinucleated, and had duplicated nuclear and cytoplasmic membranes with frequent nuclear pockets and cytoplasmic vacuoles, respectively. All neutrophilic and eosinophilic granulocytes had severe quantitative and qualitative defects of granulogenesis; autophagy and nuclear pockets were also observed in the majority of granulocytic cells. Platelets had decreased granulation and extremely dilated canaliculi. Decreased titration scores with anti-I and anti-i were observed with the patient's erythrocytes and those of his clinically normal mother. The unusual morphologic and serologic findings in this patient appear to have resulted from a membrane abnormality affecting the cells of several hematopoietic lines and their organelles.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3599130

Source DB:  PubMed          Journal:  J Submicrosc Cytol        ISSN: 0022-4782


  3 in total

Review 1.  Nuclear envelope-limited chromatin sheets (ELCS) and heterochromatin higher order structure.

Authors:  Donald E Olins; Ada L Olins
Journal:  Chromosoma       Date:  2009-06-12       Impact factor: 4.316

2.  Leukemia and chromosomal instability in aged Fancc-/- mice.

Authors:  Donna Cerabona; Zejin Sun; Grzegorz Nalepa
Journal:  Exp Hematol       Date:  2016-02-06       Impact factor: 3.084

3.  FANCA safeguards interphase and mitosis during hematopoiesis in vivo.

Authors:  Zahi Abdul-Sater; Donna Cerabona; Elizabeth Sierra Potchanant; Zejin Sun; Rikki Enzor; Ying He; Kent Robertson; W Scott Goebel; Grzegorz Nalepa
Journal:  Exp Hematol       Date:  2015-09-11       Impact factor: 3.084

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.